If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
5
Followers on Owler
Milo Biotechnology
develops therapies to increase muscle strength and prevent muscle atrophy...
Read more
Overview
Competitors
Funding
News & Insights
Milo Biotechnology
develops therapies to increase muscle strength and prevent muscle atrophy...
Read more
Founder & CEO
Al Hawkins
CEO Approval Rating
69/100
Weigh In
2012
Cleveland
Ohio
Cleveland Metropolitan Area
Private
Health Care Equipment & Services
Health Care Technology
8090
NAICS listing
http://www.milobiotechnology.com
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$1.2M
News
Latest News
Oct 06, 2018
BioPortfolio
Milo Biotechnology: Milo Biotechnology LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Jul 30, 2018
BioPortfolio
Milo Biotechnology: Milo Biotechnology LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Mar 24, 2018
BioPortfolio
Milo Biotechnology: Milo Biotechnology LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Dec 01, 2017
BioPortfolio
Milo Biotechnology: Milo Biotechnology LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Oct 15, 2017
BioPortfolio
Milo Biotechnology: Milo Biotechnology LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13092017 Prices from USD $250
May 22, 2017
BioPortfolio
Milo Biotechnology: Milo Biotechnology LLC Pharmaceuticals Healthcare Deals and Alliances Profile Updated 10052017 Prices from USD $250
Feb 27, 2017
BioPortfolio
Milo Biotechnology: Milo Biotechnology LLC Pharmaceuticals Healthcare Deals and Alliances Profile Updated 17022017 Prices from USD $250
Oct 05, 2016
Pharamceutical Technology
Milo Biotechnology: Milo Biotechnology receives orphan drug designation for AAV1-FS344 to treat inclusion body myositis
Sep 21, 2016
FinSMEs
Milo Biotechnology: Milo Biotechnology Raises Funding from JumpStart and Rev1 Ventures
Sep 20, 2016
The Business Journals
Milo Biotechnology: Nationwide Children's spinoff raises funds for muscular dystrophy gene therapy trials from Rev1, JumpStart
Follow and Get Alerts
Milo Biotechnology Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 13 + competitors
Trending Companies